Endo-glucose metabolism Flashcards
Screening criteria for DM?
How often should you screen?
Screening of adults in primary care setting with at least one of the following risk factors:
- Age >45
- Overweight or Obese
- First degree relative with DM
- History of GDM
- History of PCOS
- High risk ethnicity: Black, alaskan native, asian American, hispanic
Screen every 3 years.
Diagnostic criteria for DM
Random plasma glucose >200
Fasting plasma glucose >126
Plasma glucose during a 2hr 75g OGTT >200
Hemoglobin A1C >6.5%
Diagnostic criteria for metabolic syndrome?
1) waist circumference >40 in men and >35 in women
2) Fasting TG >150 or on drug therapy for TGs
3) HDL cholesterol: Men <40, Women <50
4) BP: Systolic >130, DS >85, or on drug therapy for hypertension
5) Fasting glucose >100
What is the best way to prevent a prediabetic from getting diabetes?
Lifestyle modifications! It has proven to decrease the risk of patients with prediabetes developing type 2 diabetes by 41-58%
What are the thiazolidinediones?
They are: troglitazone, rosiglitazome, pioglitazone
What are strategies to prevent or delay onset of type II DM?
- Diet and exercise
- Smoking cessation
- Bariatric surgery
- Metformin
- Lipase inihibitors (Orlistat)
- Thiazolidoinediones (troglitazome, rosiglitazone, pioglitazone)
Are ACEI or ARBS effective at preventing DM?
No!
What is the A1C goal for…
- Healthy adults?
- Complex health issues?
- Older adults?
- Pregnant women?
- Healthy adults: 7%
- Complex Health issues: 8% without severe recurrent hypoglycemia
- Older adults: 7-8.5% depending on how impaired they are as an older adult
- Pregnant women: >6% without severe recurrent hypoglycemia
When should you self-monitor BG?
for multiple daily insulin injections…. for once daily or non-insulin regimens, wouldn’t worry too much about it
Look at page 8, insulin pharmacokinetics
! Look
INSULIN
Mechanism of action?
Effect on weight?
Risks and Concerns?
Long-term studies on definitive outcomes?
Mechanism of action?: decreases hepatic glucose production, increases peripheral glucose uptake
Effect on weight?: increases
Risks and Concerns?: hypoglyemia
Long-term studies on definitive outcomes?: decrease in microvascular and microvascular events
SULFONYLUREAS
Mechanism of action?
Effect on weight?
Risks and Concerns?
Long-term studies on definitive outcomes?
Mechanism of action?: stimulate insulin secretion
Effect on weight?: increase
Risks and Concerns?: hypoglycemia
Long-term studies on definitive outcomes?: decrease microvascular events but possible increase in microvascular
What are the sulfonylureas?
glipize, glyburide, glicazide, glimepiride
METFORMIN
Mechanism of action?
Effect on weight?
Risks and Concerns?
Long-term studies on definitive outcomes?
Mechanism of action? decrease hepatic glucose production, increase insulin mediated uptake of glucose in muscles
Effect on weight?: neutral
Risks and Concerns? diarrhea and abdominal discomfort, lactic acidosis
Long-term studies on definitive outcomes?: decrease micro and microvascular
THIAZOLIDINEDIONES
Mechanism of action?
Effect on weight?
Risks and Concerns?
Long-term studies on definitive outcomes?
Mechanism of action? increase peripheral glucose uptake
Effect on weight? neutral
Risks and Concerns? fluid retention
Long-term studies on definitive outcomes? may be harmful?
GLP-1 mimetics
Mechanism of action?
Effect on weight?
Risks and Concerns?
Long-term studies on definitive outcomes?
Mechanism of action?: slows gastric emptying, suppress glucagon secretion, increase satiety
Effect on weight? decrease
Risks and Concerns? hypoglycemia, nausea, pancreatitis
Long-term studies on definitive outcomes? none
GLP-1 mimetics
exenatide and liraglutide
DPP-4 inhibitors
sitagliptin, saxagliptin, vildagliptin, linagliptin, alogliptin
DPP-4 INHIBITORS
Mechanism of action?
Effect on weight?
Risks and Concerns?
Long-term studies on definitive outcomes?
Mechanism of action?: slows gastric emptying
Effect on weight?: neutral
Risks and Concerns? hypoglycemia
Long-term studies on definitive outcomes? none, but also increased risk of hospitalization for heart failure with saxagliptin
SGLT2 inhibitors
dapaglifozin and canagliflozin
SGTL2 inhibitors
Mechanism of action?
Effect on weight?
Risks and Concerns?
Long-term studies on definitive outcomes?
Mechanism of action? increases kidney excretion of glucose
Effect on weight? Decrease
Risks and Concerns? hypoglycemia, kidney impairment
Long-term studies on definitive outcomes?none
Inpatient blood glucose targets?
<140 premeal
<180 random
What is the differential diagnosis of spontaneous fasting hypoglycemia in patient w/o diabetes?
insulinoma
surreptitious use of sulfonylureas
surreptitious use of insulin
insulin autoimmune hypoglycemia
What is a sign of surreptitious insulin use
C-peptide will be low!